{
    "clinical_study": {
        "@rank": "94256", 
        "acronym": "METTRO", 
        "arm_group": [
            {
                "arm_group_label": "Clasical Surveillance of AVF", 
                "arm_group_type": "Other", 
                "description": "As recommended by vascular access guidelines AVF is evaluated following the next items.\nPredialysis physical examination of AVF every dialysis session.\nEffective blood flow, venous pressure, arterial pressure, at the beginning and at the end of the dialysis session.\nWeekly ktv measurement using biosensors. In patients who have been dialyzed in monitors with no biosensors, ktv will be measured monthly using monocompartimental Daugirdas equation.\nQuarterly recirculation with urea method.\nIn accordance with Spanish Nephrology VA guidelines the following will be consider as alarm criteria:\n25% Increased venous pressure.\n25% Decreased pump blood flow.\n0,2 ktv decreased compared with previous measurement.\nMore than 10% recirculation using urea method.\nProlonged coagulation time in three consecutive dialysis sessions.\nCannulation problems in three consecutive dialysis sessions.\nPathologic physical examination with any of the previous criteria."
            }, 
            {
                "arm_group_label": "Second generation surveillance of AVF", 
                "arm_group_type": "Experimental", 
                "description": "In addition to the classical surveillance and monitoring methods, in the experimental group Doppler ultrasound and transonic dilution method will be performed on a quarterly basis.\nIn addition to the classical alarm criteria and derived from the results in Doppler ultrasound an transonic dilution method the following alarm criteria would also be considered  in the experimental group:\n25% or higher decreased in QA compared with previous measurement.\nQA lower than 500 ml/min.\nStenotic area with a higher than 50% reduction of blood vessel lumen would be considered as alarm criteria only if it comes with a haemodynamic repercussion criteria defined as Peak systolic velocity (PSV) higher than 400 cm/sc, aliasing, or PSV ratio stenosis/pre-stenosis higher than 3."
            }
        ], 
        "brief_summary": {
            "textblock": "All vascular access guidelines recommend monitoring and surveillance protocols to prevent\n      vascular access complications in hemodialysis units.\n\n      However, in the case of second generation screening techniques which determine access blood\n      flow measurement (QA), there is a huge controversy about it\u00b4s efficiency.\n\n      Although multiple observational studies find a decrease in the thrombosis rate and an\n      increased primary assisted patency survival related to the use of these techniques, a\n      recently published meta-analysis find contradictory results in the randomized controlled\n      trials, affirming that the measurement of QA  is useless in grafts and questionable in\n      native arteriovenous fistulae (AVF).\n\n      We have designed a multicenter, prospective, open label, controlled, randomized trial, to\n      prove the usefulness of the QA measurement using two complementary second generation\n      techniques, Doppler ultrasound and Transonic dilution method, compared to the classical\n      monitoring and surveillance methods.\n\n      The primary endpoint will be a reduction in the thrombosis rate with an increased assisted\n      primary patency survival, and a cost effectiveness economic analysis.\n\n      As secondary endpoints we will analyze the impact over non-assisted primary patency survival\n      and secondary patency survival."
        }, 
        "brief_title": "Second Generation Surveillance Methods To Prevent Thrombosis And Increase Assisted Primary Patency Survival In Native Arteriovenous Fistulae", 
        "condition": "Thrombosis in Native Arteriovenous Fistulae.", 
        "condition_browse": {
            "mesh_term": [
                "Arteriovenous Fistula", 
                "Fistula", 
                "Thrombosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Definition:\n\n      Multicenter, prospective, open label, controlled, randomized trial, to prove the usefulness\n      of the QA measurement using two complementary second generation techniques, Doppler\n      ultrasound and Transonic dilution method, compared to the classical monitoring and\n      surveillance methods.\n\n      For Patient Registries:\n\n      Clinical data repository (CDR) paper notebook will contain all baseline patient\n      characteristics and the information related to vascular access. These data will be collected\n      by the different investigators and reviewed and included in data base by the study\u00b4s\n      monitor.\n\n      This information will be included in a centralized computer database (SPSS 15.0 computer\n      system) and encoded in order to preserve patients\u00b4 confidentiality."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent signature.\n\n          -  Age between 18 and 95 years old.\n\n          -  Functioning native AVF.\n\n          -  Patients with end stage renal disease (ESRD) undergoing hemodialysis program for at\n             least three months.\n\n        Exclusion Criteria:\n\n          -  Coagulopathy or hemoglobinopathy of any cause.\n\n          -  Hospitalization of any cause in the previous month.\n\n          -  VA related complications or dysfunction in the previous three months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "212", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02111655", 
            "org_study_id": "210443-031132-261233", 
            "secondary_id": "3598"
        }, 
        "intervention": [
            {
                "arm_group_label": "Second generation surveillance of AVF", 
                "description": "Doppler ultrasound and transonic dilution method technique will be performed in the experimental group quarterly.\nQA  will be measured by both techniques and haemodynamic repercussion stenosis will be evaluated by doppler ultrasound.", 
                "intervention_name": "Second generation surveillance of AVF", 
                "intervention_type": "Device", 
                "other_name": [
                    "Doppler ultrasound: M-Turbo. Sonosite.", 
                    "Transonic dilution method: Transonic System Inc HD-03"
                ]
            }, 
            {
                "arm_group_label": "Clasical Surveillance of AVF", 
                "description": "Effective blood flow, venous pressure, arterial pressure, at the beginning and at the end of the dialysis session", 
                "intervention_name": "vital signs", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Clasical Surveillance of AVF", 
                "description": "Predialysis physical examination of AVF every dialysis session.", 
                "intervention_name": "physical examination of AVF", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Clasical Surveillance of AVF", 
                "description": "Weekly ktv measurement using biosensors. In patients who have been dialyzed in monitors with no biosensors, ktv will be measured monthly using monocompartimental Daugirdas equation", 
                "intervention_name": "ktv test", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Clasical Surveillance of AVF", 
                "description": "Quarterly recirculation with urea method.", 
                "intervention_name": "urea method", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Thrombosis", 
            "Arteriovenous fistulae", 
            "Hemodialysis", 
            "Doppler ultrasound", 
            "Vascular access blood flow", 
            "Surveillance"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Sebastian de Los Reyes", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28702"
                    }, 
                    "name": "Hospital Universitario Infanta Sofia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "Centro de Di\u00e1lisis Los Enebros"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28027"
                    }, 
                    "name": "Clinica Fuensanta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28009"
                    }, 
                    "name": "Dialcentro"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "Hospital Universitario Gregorio Mara\u00f1on"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "SECOND GENERATION SURVEILLANCE TECHNIQUES (METHODS) TO PREVENT THROMBOSIS AND INCREASE ASSISTED PRIMARY PATENCY SURVIVAL IN NATIVE ARTERIOVENOUS FISTULAE. A PROSPECTIVE CONTROLLED TRIAL", 
        "overall_official": [
            {
                "affiliation": "HOSPITAL UNIVERSITARIO INFANTA SOFIA", 
                "last_name": "ANTONIO CIRUGEDA, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARIO INFANTA SOFIA", 
                "last_name": "SILVIA CALDES, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "CLINICA FUENSANTA", 
                "last_name": "YESIKA AMEZQUITA, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARIO GREGORIO MARA\u00d1ON", 
                "last_name": "JUAN MANUEL LOPEZ, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARIO GREGORIO MARA\u00d1ON", 
                "last_name": "SORAYA ABAD, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Infanta Sofia", 
                "last_name": "INES ARAGONCILLO, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Differences in assisted primary patency rates (thrombosis free access survival) in AVF between the two groups: control group in which classical monitoring and surveillance techniques are applied and experimental group in which Doppler ultrasound and transonic were performed every three months in addition to classical methods.\nCost efficacy analysis in both groups will be done, measuring all vascular access (VA) related health care spending (VA hospitalization costs, central venous catheter (CVC) placements, surgeries and endovascular procedures will be recorded).", 
                "measure": "Improved primary patency rate in arteriovenous fistulae with the use of doppler ultrasound and transonic dilution method", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year follow up"
            }, 
            {
                "description": "Differences in assisted primary patency rates (thrombosis free access survival) in AVF between the two groups: control group in which classical monitoring and surveillance techniques are applied and experimental group in which Doppler ultrasound and transonic were performed every three months in addition to classical methods.\nCost efficacy analysis in both groups will be done, measuring all vascular access (VA) related health care spending (VA hospitalization costs, central venous catheter (CVC) placements, surgeries and endovascular procedures will be recorded).", 
                "measure": "Improved primary patency rate in arteriovenous fistulae with the use of doppler ultrasound and transonic dilution method", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years follow up"
            }, 
            {
                "description": "Differences in assisted primary patency rates (thrombosis free access survival) in AVF between the two groups: control group in which classical monitoring and surveillance techniques are applied and experimental group in which Doppler ultrasound and transonic were performed every three months in addition to classical methods.\nCost efficacy analysis in both groups will be done, measuring all vascular access (VA) related health care spending (VA hospitalization costs, central venous catheter (CVC) placements, surgeries and endovascular procedures will be recorded).", 
                "measure": "Improved primary patency rate in arteriovenous fistulae with the use of doppler ultrasound and transonic dilution method", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years follow up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02111655"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Compared non-assisted primary patency rates (intervention free access survival) and secondary patency rates (access survival until abandonment) between the two groups.", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year follow up"
            }, 
            {
                "description": "It will be evaluated the positive and negative predictive value of each second generation technique, doppler ultrasound and Transonic dilution method. The accuracy of these techniques will be compared to determine which one show more benefits detecting pathology of AVF.", 
                "measure": "Evaluate the efficacy and efficiency of second generation methods", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years follow up"
            }, 
            {
                "description": "There will be always two observers for each doppler ultrasound (same observers for same AVF). Differences among different quarterly measures in stable AVF will be evaluated, as well as the differences between the two observers in QA measurement.", 
                "measure": "Reproducibility in Doppler ultrasound technique", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years follow up."
            }, 
            {
                "description": "It will be evaluated if there is any influence of age, body mass index, use of antiplatelet therapy, anticoagulant therapy and the use of pentoxifylline in the risk of thrombosis of AVF", 
                "measure": "Possible influence of different baseline items in the risk of thrombosis of native AVF", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years follow up"
            }, 
            {
                "measure": "Compared non-assisted primary patency rates (intervention free access survival) and secondary patency rates (access survival until abandonment) between the two groups.", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 years follow up"
            }, 
            {
                "description": "It will be evaluated the positive and negative predictive value of each second generation technique, doppler ultrasound and Transonic dilution method. The accuracy of these techniques will be compared to determine which one show more benefits detecting pathology of AVF.", 
                "measure": "Evaluate the efficacy and efficiency of second generation methods", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years follow up"
            }, 
            {
                "measure": "Compared non-assisted primary patency rates (intervention free access survival) and secondary patency rates (access survival until abandonment) between the two groups.", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years follow up"
            }
        ], 
        "source": "Hospital Infanta Sofia", 
        "sponsors": {
            "collaborator": {
                "agency": "SOMANE (MADRID SOCIETY OF NEPHROLOGY)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Hospital Infanta Sofia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}